Indications and uses
For use in the management of closed hyperproliferative (hypertrophic or keloid) scars, resulting from general surgical procedures, trauma, wounds, and burns.
For use in the management of closed hyperproliferative (hypertrophic or keloid) scars, resulting from general surgical procedures, trauma, wounds, and burns.
1. Ensure that the affected area is clean and dry. 2. Apply Scarcin ROLL-ON to the area as a very thin coat and allow to dry. 3. Apply Scarcin ROLL-ON twice a day 4. Once dry, Scarcin ROLL-ON can be covered with cosmetics or sunscreen. 5. Recommended duration of treatment is 60-90 days. How is SCARCIN ROLL-ON Supplied SCARCIN ROLL-ON is supplied in: 3 oz Roll-on bottle NDC: 69420-8003-1 Store at 20°-25°C (68° to 7...
-----------------------------
SCARCIN ROLL-ON
Rx only
For external use only
Not for ophthalmic use
SCARCIN ROLL-ON is intended for use in the management of closed hyperproliferative scars, both old and new hypertrophic or keloid scars resulting from burns, surgical procedures or trauma wounds. It helps reduce redness, softens and flattens raised scars, relieves itching, discomfort and pain associated with scars, helps prevent excessive and abnormal scar formation, and for use as mono-therapy or in combination with other scar therapies including pressure garments.
SCARCIN ROLL-ON is a self-drying, flexible, gas permeable, waterproof silicone liquid mixture that is colorless and odorless. SCARCIN ROLL-ON forms a bond with the stratum corneum (the outer layer of dead skin cells) forming a protective barrier against chemical physical and microbial invasion of the scar site while assisting with hydration.
SCARCIN ROLL-ON is also for use on children or people with sensitive skin. Silicone is internationally recommended as the first line of treatment in scar management.
SCARCIN ROLL-ON contains: Dimethicone, Dimethiconol, Cyclopentasiloxane, Cyclotetrasiloxane, Silicon, Stearyl Alcohol
The exact mechanism of action in improving the appearance of scar tissue from using silicone remains unknown. However, various suggestions have been made to explain the efficacy of silicone, including hydration, pressure, temperature, oxygen transmission and silicone absorption. There is some evidence that the treatment affects the stratum corneum and, by reducing evaporation, restores better homeostasis in the tissue. In keloid and hypertrophic scarring, the stratum corneum allows more evaporation of water from the underlying tissue than occurs in normal skin. Silicone may prevent this, keeping the stratum corneum in optimal hydration and protecting the skin from environmental hazards, both of which can reduce abnormal scarring. The liquid may also affect the stratum corneum by inhibiting mast cell activity, diminishing edema, vasodilatation and excessive extracellular matrix formation but the simple changes in temperature, pressure, oxygen tension and hydration produced by wound coverage probably constitute the main mechanism of action. Another hypothesis is that the effect of static electricity on silicone may influence the alignment of collagen deposition.
For use in the management of closed hyperproliferative (hypertrophic or keloid) scars, resulting from general surgical procedures, trauma, wounds, and burns.
SCARCIN ROLL-ON is contraindicated in patients with known hypersensitivity to silicone or any of the listed ingredients.
For external use only. Avoid direct contact with eyes, lips or mucous membranes. Do not apply on areas of broken skin. Do not apply on third degree burns and open wounds. Never use on sutured wound until sutures have been removed. Do not use on dermatological conditions that disrupt the integrity of the skin.
Stop use and ask a doctor if irritation develops. In rare instances, silicone liquid may cause a rash on the skin. This condition may result from improper cleansing of the scar area where the silicone gel has been applied. If this product is applied properly and skin irritation still occurs, discontinue use and consult your physician. If ingested, get medical help or contact Poison Control Center right away.
KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.
This medication should be used as directed by your physician during pregnancy or while breastfeeding. Consult your doctor about the risks and benefits.
CAUTION: Federal law restricts this device to sale by or on the order of a physician.
On rare occasions, the silicone liquid may cause temporary redness, stinging, burning or irritation and normally disappear when the medication is discontinued.
1. Ensure that the affected area is clean and dry.
2. Apply Scarcin ROLL-ON to the area as a very thin coat and allow to dry.
3. Apply Scarcin ROLL-ON twice a day
4. Once dry, Scarcin ROLL-ON can be covered with cosmetics or sunscreen.
5. Recommended duration of treatment is 60-90 days.
How is SCARCIN ROLL-ON Supplied
SCARCIN ROLL-ON is supplied in:
3 oz Roll-on bottle
NDC: 69420-8003-1
Store at 20°-25°C (68° to 77°F); Keep away from heat and protect from freezing. [See USP Controlled Room Temperature.]
Manufactured for:
SA3, LLC
Los Angeles, CA 90064
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0069420800317 | GTIN-13: 0069420800317 EAN-13: 0069420800317 GTIN-12: 069420800317 UPC-A: 069420800317 GTIN storage (14 digits): 00069420800317 | scarcin-roll-on-1.jpg |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69420-8003-1 | ML - Milliliter | 69420-8003 | 976671a8-a1cf-4789-968a-5f5f42921068 | 1 | 2018-09-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69420-8003 | 69420-8003-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMETHICONE | 92RU3N3Y1O | IACT |
| DIMETHICONOL (2000 CST) | T74O12AN6Y | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| CYCLOMETHICONE 4 | CZ227117JE | IACT |
| SILICON | Z4152N8IUI | IACT |
| STEARYL ALCOHOL | 2KR89I4H1Y | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.